These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interstitial pneumonia recurrence during chronic hepatitis C treatment. Renou C; Germain S; Harafa A; Martin S; Larroque O; Muller P; Bertrand JJ; Halfon P Am J Gastroenterol; 2005 Jul; 100(7):1625-6. PubMed ID: 15984999 [No Abstract] [Full Text] [Related]
3. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C. Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients. Vasilij Benatti S; Giampaolo Q; Sara B; Marco R; Diego R AIDS; 2014 Nov; 28(17):2633-5. PubMed ID: 25574965 [No Abstract] [Full Text] [Related]
5. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS. Abi-Nassif S; Mark EJ; Fogel RB; Hallisey RK Chest; 2003 Jul; 124(1):406-10. PubMed ID: 12853555 [TBL] [Abstract][Full Text] [Related]
6. Interstitial pneumonitis in a patient with chronic hepatitis C and chronic renal failure on interferon therapy. Kang EJ; Kim DK; Jeon SR; Choi HS; Jeong SW; Jang JY; Lee JS; Uh ST Korean J Gastroenterol; 2011 Jul; 58(1):47-52. PubMed ID: 21778804 [TBL] [Abstract][Full Text] [Related]
7. Interstitial pneumonitis after treatment for hepatitis C virus infection. Botnaru V; Munteanu O; Rusu D Pneumologia; 2015; 64(1):46-50. PubMed ID: 26016056 [TBL] [Abstract][Full Text] [Related]
8. Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection. Torres-Macho J; Jara-Chinarro B; Suárez-Aliaga B; Gámez-Díez S; García-de-Casasola G; de-Cuenca-Morón B Rev Esp Enferm Dig; 2010 Oct; 102(10):606-8. PubMed ID: 21039072 [TBL] [Abstract][Full Text] [Related]
9. Interstitial pneumonitis associated with pegylated interferon alpha-2b therapy for chronic hepatitis C: case report. Carrillo-Esper R; González-Avila D; Uribe-Ríos M; Méndez-Sánchez N Ann Hepatol; 2008; 7(1):87-90. PubMed ID: 18376374 [TBL] [Abstract][Full Text] [Related]
10. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis. Shimada M; Yoshida S; Kornek M; Kim SJ; Schuppan D Liver Int; 2010 Nov; 30(10):1552-4. PubMed ID: 20557455 [No Abstract] [Full Text] [Related]
11. Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C. Chen YC; Lu SN; Lin MC Chang Gung Med J; 2007; 30(1):92-7. PubMed ID: 17477035 [TBL] [Abstract][Full Text] [Related]
12. Interstitial pneumonitis during combination therapy with interferon-alpha and ribavirin in a patient with chronic Hepatitis C. Rothfuss KS; Bode JC Z Gastroenterol; 2002 Sep; 40(9):807-10. PubMed ID: 12215950 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous occurrence of pleural effusion and interstitial pneumonitis after treatment with pegylated interferon for hepatitis C virus infection. Ji F; Li Z; Xue H; Liu L; Deng H South Med J; 2011 Feb; 104(2):140-2. PubMed ID: 21206334 [TBL] [Abstract][Full Text] [Related]
14. [Clinical features of interstitial pneumonitis due to interferon alpha therapy for chronic hepatitis C]. Ji FP; Li ZX; Deng H; Xue HA; Liu Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):667-70. PubMed ID: 19403391 [TBL] [Abstract][Full Text] [Related]
15. [Respiratory function impairment during treatment of chronic hepatitis C with peginterferon alfa2 and ribavirin. Two cases presentation]. Biedroń-Machura M; Musialik J; Sozańska E; Zbroszczyk M; Baron J; Błońska-Fajfrowska B; Pierzchała W Wiad Lek; 2012; 65(4):232-8. PubMed ID: 23654144 [TBL] [Abstract][Full Text] [Related]
16. [Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C]. Son BK; Sohn JH; Kim TY; Park YK; Jeon YC; Han DS Korean J Hepatol; 2007 Mar; 13(1):103-7. PubMed ID: 17380081 [TBL] [Abstract][Full Text] [Related]
17. Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. Foster GR; Zeuzem S; Pianko S; Sarin SK; Piratvisuth T; Shah S; Andreone P; Sood A; Chuang WL; Lee CM; George J; Gould M; Flisiak R; Jacobson IM; Komolmit P; Thongsawat S; Tanwandee T; Rasenack J; Sola R; Messina I; Yin Y; Cammarata S; Feutren G; Brown KK J Viral Hepat; 2013 Apr; 20(4):e115-23. PubMed ID: 23490379 [TBL] [Abstract][Full Text] [Related]
18. [Pegylated interferon-alpha for the treatment of chronic hepatitis C]. Weis NM; Krarup HB; Skinhøj P Ugeskr Laeger; 2003 Oct; 165(44):4211-5. PubMed ID: 14621552 [No Abstract] [Full Text] [Related]
19. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha]. Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017 [No Abstract] [Full Text] [Related]
20. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply. Hu CC; Chien RN Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679 [No Abstract] [Full Text] [Related] [Next] [New Search]